Health Care & Life Sciences » Pharmaceuticals | Chong Kun Dang Pharmaceutical Corp.

Chong Kun Dang Pharmaceutical Corp. | Mutual Funds

Mutual Funds that own Chong Kun Dang Pharmaceutical Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Government Pension Fund - Global (The)
106,355
1.08%
-7,890
0%
12/31/2017
Vanguard Total International Stock Index Fund
87,616
0.89%
0
0%
07/31/2018
iShares Core MSCI Emerging Markets ETF
62,049
0.63%
0
0.01%
09/05/2018
Victory Munder International Small Cap Fund
52,829
0.54%
5,548
0.28%
06/30/2018
DFA Emerging Markets Core Equity Portfolio
49,978
0.51%
768
0.02%
04/30/2018
DFA Emerging Markets Small Cap Series
48,123
0.49%
0
0.06%
01/31/2018
Vanguard Developed Markets Index Fund
34,960
0.35%
0
0%
07/31/2018
28,943
0.28%
6,683
0.44%
05/31/2018
CREF Stock Account
27,685
0.28%
0
0%
03/31/2018
Mirae Asset TIGER 200
25,067
0.25%
2,463
0.09%
01/31/2018

About Chong Kun Dang Pharmaceutical

View Profile
Address
8 Chungjeong-ro
Seoul SL 03742
Korea, Republic Of
Employees -
Website http://www.ckdpharm.com
Updated 07/08/2019
Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. Its products include medicine for antidiabetic, antivirus, beta-blocking, anti-hyperlipidemia and others. The company was founded on November 2, 2013 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.